The AKT inhibitor MK-2206 attenuated DNA synthesis in all four glioblastoma cell lines with similar efficiency (EC50 = 4.6–7.1 μM, Figure 1C, Table 2). This evidence concerns the gene AKT1 and glioblastoma.